LAMEA Skin Cancer Diagnostics Market

LAMEA Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Non-Melanoma and Melanoma), By Test Type (Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others), ByEnd-use, By Country and Growth Forecast, 2024 - 2031

Report Id: KBV-23733 Publication Date: July-2024 Number of Pages: 110
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Latin America, Middle East and Africa Skin Cancer Diagnostics Market would witness market growth of 7.6% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Skin Cancer Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $267.1 million by 2031. The Argentina market is showcasing a CAGR of 8.3% during (2024 - 2031). Additionally, The UAE market is registering a CAGR of 6.6% during (2024 - 2031).

LAMEA Skin Cancer Diagnostics Market

The skin cancer diagnostics market has become a critical segment of the broader healthcare industry as a result of the increasing prevalence of skin cancer. As one of the most common forms of cancer, skin cancer includes various types, primarily categorized into melanoma and non-melanoma skin cancers (NMSC).

Additionally, the increasing incidence of these cancers has driven significant advancements in diagnostic technologies and methods, transforming the landscape of dermatological care. This market is influenced by many factors, ranging from demographic shifts and lifestyle changes to technological innovations and healthcare policies.

In numerous LAMEA countries, the prevalence of cutaneous cancer is increasing. This is attributed to increased sun exposure due to outdoor lifestyles and occupations and a lack of public awareness about skin cancer prevention. This rise in cases fuels the need for accessible and efficient diagnostic tools. In Brazil, the rising incidence of skin cancer is closely linked to increasing awareness and the implementation of extensive screening programs. According to the World Cancer Research Fund, Brazil reported 9,676 new cases of skin cancer in 2022.

Free Valuable Insights: The Worldwide Skin Cancer Diagnostics Market is Projected to reach USD 12.8 Billion by 2031, at a CAGR of 5.3%

Based on Type, the market is segmented into Non-Melanoma and Melanoma. Based on Test Type, the market is segmented into Skin Biopsy, Imaging Tests, Dermatoscopy, Lymph Node Biopsy, and Others. Based on End-use, the market is segmented into Hospital & Clinics, Laboratories, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

List of Key Companies Profiled

  • Castle Biosciences, Inc.
  • Bausch Health Companies, Inc. (DermTech, Inc.)
  • Canfield Scientific, Inc.
  • DermaSensor, Inc.
  • F.Hoffmann-La Roche Ltd.
  • NeoGenomics, Inc.
  • Quest Diagnostics Incorporated.
  • Digital Diagnostics, Inc. (3Derm Systems, Inc.)
  • FotoFinder Systems GmbH
  • Veriskin Inc

LAMEA Skin Cancer Diagnostics Market Report Segmentation

By Type

  • Non-Melanoma
  • Melanoma

By Test Type

  • Skin Biopsy
  • Imaging Tests
  • Dermatoscopy
  • Lymph Node Biopsy
  • Others

By End-use

  • Hospital & Clinics
  • Laboratories
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo